Circulating Tumor Cells (CTCs) in Advanced Gastric Cancer
NCT ID: NCT01848015
Last Updated: 2015-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2013-06-30
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To identify the relationship between the detection of circulation tumor cells and recurrence patterns of gastric cancer after radical resection.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal Cancer
NCT03400657
CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients
NCT04917289
Prediction of the Efficacy of ctDNA in Immunotherapy for Advanced Gastric Cancer
NCT04053725
Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal Cancer
NCT02955173
Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric Cancer
NCT03427684
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CTCs positive
detection of CTCs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
detection of CTCs
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ageā„ 18 years old
* Histologically confirmed gastric adenocarcinoma
* Preoperative clinical examination and imaging indicating operable disease
* complete resection (R0 resection)
* D2 or D2+ resection
Exclusion Criteria
* Patients who have been given preoperative chemotherapy/chemoradiation.
* Staging investigations or intraoperative exploration indicating inoperable disease
* R1 or R2 resection
* D0 or D1 resection
* Patients unreliable for follow up
* Past history of malignancy
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shen Lin
Director of GI oncology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lin Shen, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Peking University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking cancer hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Zhang Q, Shan F, Li Z, Gao J, Li Y, Shen L, Ji J, Lu M. A prospective study on the changes and clinical significance of pre-operative and post-operative circulating tumor cells in resectable gastric cancer. J Transl Med. 2018 Jun 20;16(1):171. doi: 10.1186/s12967-018-1544-1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CGOG5003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.